Evidence map›Paper›PMID 25070941›Full record

ArticleThe Journal of infectious diseases2015

Advanced immune suppression is associated with increased prevalence of mixed-strain Mycobacterium tuberculosis infections among persons at high risk for drug-resistant tuberculosis in Botswana.

Sanghyuk S Shin, Chawangwa Modongo, Ronald Ncube, Enoch Sepako, Jeffrey D Klausner, Nicola M Zetola

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of infectious diseases, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 2 pooled it
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 2 syntheses or guidelines pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Genetic Profile of Linezolid-ResistantAntibiotics (Basel, Switzerland) · 2021
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Tuberculosis research and treatment · 2018
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 2 countries.

Sanghyuk S ShinDivision of Infectious Diseases, University of California-Los Angeles.
Chawangwa ModongoBotswana-Upenn Partnership.
Ronald NcubeBotswana National Tuberculosis Program, Botswana Ministry of Health.
Enoch SepakoUniversity of Botswana, Gaborone, Botswana.
Jeffrey D KlausnerDivision of Infectious Diseases, University of California-Los Angeles.
Nicola M ZetolaBotswana-Upenn Partnership Division of Infectious Diseases, University of Pennsylvania, Philadelphia.
University of California, Los Angeles · USBotswana Harvard AIDS Institute Partnership · BWMinistry of Health · BWUniversity of Botswana · BWUniversity of Pennsylvania · US

Funding

Virus & Reservoirs CoreP30AI045008 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI DAVID S METZGER · 1999 to 2026
$78.6M
UCLA Clinical and Translational Science InstituteUL1TR000124 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DUBINETT, STEVEN M. · 2012 to 2015
$57.0M
UCLA Rapid, Relevant, Rigorous Implementation Science HubP30MH058107 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Nina Thawata Harawa · 1997 to 2026
$53.5M
Virology CoreP30AI028697 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI KITCHEN, SCOTT G · 1991 to 2018
$39.9M
Postdoctoral Training in Global AIDS Prevention ResearchT32MH080634 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI JESSE LAWTON CLARK, Pamina Mae Gorbach · 2007 to 2026
$6.4M
Dynamics of TB and MDR TB transmission in areas with high HIV prevalenceR01AI097045 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI ZETOLA, NICOLA MARIO · 2011 to 2015
$2.9M
Determination of Exhaled Biomarkers for Low-Cost Diagnosis and Monitoring of TBR21AI105611 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI ZETOLA, NICOLA MARIO · 2014 to 2015
$340k
NCATS NIH HHS UL1 TR000124NCATS NIH HHS UL1TR000124NIAID NIH HHS 5P30AI028697NIAID NIH HHS P30 AI028697NIAID NIH HHS P30 AI045008NIAID NIH HHS P30AI45008NIAID NIH HHS R01 AI097045NIAID NIH HHS R01AI097045NIAID NIH HHS R21 AI105611NIMH NIH HHS MH58107NIMH NIH HHS P30 MH058107NIMH NIH HHS T32 MH080634NIMH NIH HHS T32MH080634
6 · The paper itself

Abstract

We examined factors associated with mixed-strain Mycobacterium tuberculosis infections among patients at high risk for drug-resistant tuberculosis in Botswana. Thirty-seven (10.0%) of 370 patients with tuberculosis had mixed M. tuberculosis infections, based on 24-locus mycobacterial interspersed repetitive unit-variable number of tandem repeats genotyping. In log-binomial regression analysis, age <37 years (adjusted prevalence ratio [PR], 1.92; 95% confidence interval [CI], 1.01-3.57) and prior tuberculosis treatment (adjusted PR, 2.31; 95% CI, 1.09-4.89) were associated with mixed M. tuberculosis infections. Among human immunodeficiency virus-infected patients, prior tuberculosis treatment (adjusted PR, 2.11; 95% CI, 1.04-4.31) and CD4(+) T-cell count of <100 cells/μl (adjusted PR, 10.18; 95% CI, 2.48-41.71) were associated with mixed M. tuberculosis infections. Clinical suspicion of mixed M. tuberculosis infections should be high for patients with advanced immunosuppression and a prior history of tuberculosis treatment.

Indexed as

AdultBotswanaCD4-Positive T-LymphocytesCoinfectionFemaleGenotypeHumansImmune ToleranceMaleMycobacterium tuberculosisPrevalenceRetrospective StudiesRiskTuberculosis, Multidrug-ResistantHIV/AIDSimmune suppressionmixed tuberculosis infectionreinfectiontuberculosis

Identifiers

PMID25070941
PMCPMC4351373
OpenAlexW2119889746

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.